Why Ultraprocessed Foods Overwhelm Human Metabolic Biochemistry

David Kessler has proposed a molecular mechanism with direct clinical implications: the gastrointestinal absorption kinetics of ultraprocessed formulations exceed the parameters human metabolic biochemistry was designed to regulate. Drawing a parallel to his 1990s campaign against the tobacco industry, Kessler characterizes these products as "energy-dense, highly palatable, rapidly absorbable" — and links their widespread consumption to the greatest documented increase in chronic disease in modern history.

The GRAS loophole as a structural gap

At the center of Kessler's analysis sits a 67-year-old regulatory designation: GRAS (generally recognized as safe). As reported by CBS, HHS Secretary Robert F. Kennedy Jr. contends that this 1958 Congressional exemption allows food manufacturers to self-certify ingredient safety without mandatory FDA review. HHS data indicates that approximately 70% of Americans are now classified as overweight or obese — a trajectory the Secretary attributes less to behavioral indolence than to a food supply engineered for hyperpalatability over nutritional density.

The pharmacological framing warrants scrutiny. Ultraprocessed formulations are constructed for rapid glycemic absorption, minimal mastication effort, and dopaminergic reward-pathway activation — properties that data suggests override homeostatic satiety signaling. The clinical endpoints Kessler enumerates — type 2 diabetes, pre-diabetes, hypertension, dyslipidemia, hepatic steatosis — share insulin resistance as a common pathophysiological node, consistent with chronic exposure to rapidly absorbable carbohydrate matrices.

Parallel regulatory pressure: bioengineered labeling

A separate development reported by Food Dive introduces another variable. A federal court ruled in 2025 that the USDA "committed legal error" by exempting highly refined ingredients from bioengineered food disclosure standards. The judgment compels USDA to revise labeling rules by 2028. Highly refined oils — a structural component of most ultraprocessed products — had been excluded because detectable genetic modification often falls below analytical thresholds post-refining. The Center for Food Safety estimates approximately 70% of all GMO-derived food ingredients were previously shielded from mandatory disclosure; the court characterized QR-code-only labeling as "deficient" for consumer accessibility. USDA retains discretion on detectability standards, meaning the revised rule may not automatically trigger labeling for every highly refined bioengineered product.

Verification protocol and verdict

The available evidence supports a methodical audit approach:

• Prioritize products with identifiable whole-food ingredients (legumes, intact grains, single-source oils) over those listing starches, protein isolates, and emulsifiers as primary constituents.
• Compare declared protein content against fiber content; ultraprocessed formulations typically deliver protein without the fiber matrix required for normal incretin signaling.
• Track postprandial glucose response over a two-week period, alternating whole-food meals against reformulated products, to quantify individual metabolic cost.
• Verify bioengineered status at point of purchase; post-2028, QR-code-only disclosure will no longer satisfy revised regulatory standards.

The biochemical mechanism implied by Kessler's framing — chronic exposure to rapidly absorbable, hyperpalatable matrices driving insulin resistance and downstream cardiometabolic pathology — is consistent with the documented epidemiological trajectory. Statistical significance across multiple chronic disease endpoints strengthens, rather than weakens, the hypothesis. Dietary decisions cannot be deferred pending federal action. Readers who routinely audit structural exposure in other domains — the same discipline applied to trading strategies and platform control for US forex traders — will find ingredient-list scrutiny familiar territory.